FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

marco gobbi

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Matilde Y Follo; marco gobbi; Lucia Manzoli; Alberto M Martelli; S Mongiorgi; M Piazzi; D Russo; C Clissa; C Colombi; C Filì; Carlo Finelli; Lucio Cocco
Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment.
Michele Cea; Gabriella Cirmena; Anna Garuti; Ilaria Rocco; Claudia Palermo; Antonia Cagnetta; Eva Moran; Nicoletta Colombo; Raffaella Grasso; Giuseppina Fugazza; marco gobbi; Alessio Nencioni; Alberto Ballestrero; Franco Patrone
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Patrizia Piccioli; Giuseppe Balbi; Martina Serra; Anna Morabito; Teresa Lamparelli; marco gobbi; Stefania Laurent; Beatrice Dozin; Paolo Bruzzi; Anna Maria Ferraris; Andrea Bacigalupo; Rosario Notaro; Maria Pia Pistillo
CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of marco gobbi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Matilde Y Follo; marco gobbi; Lucia Manzoli; Alberto M Martelli; S Mongiorgi; M Piazzi; D Russo; C Clissa; C Colombi; C Filì; Carlo Finelli; Lucio Cocco
Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment.
Leukemia 2012;26(5):943-50.
2010: Michele Cea; Gabriella Cirmena; Anna Garuti; Ilaria Rocco; Claudia Palermo; Antonia Cagnetta; Eva Moran; Nicoletta Colombo; Raffaella Grasso; Giuseppina Fugazza; marco gobbi; Alessio Nencioni; Alberto Ballestrero; Franco Patrone
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Leukemia research 2010;34(9):e240-2.
2010: Patrizia Piccioli; Giuseppe Balbi; Martina Serra; Anna Morabito; Teresa Lamparelli; marco gobbi; Stefania Laurent; Beatrice Dozin; Paolo Bruzzi; Anna Maria Ferraris; Andrea Bacigalupo; Rosario Notaro; Maria Pia Pistillo
CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Annals of hematology 2010;89(6):613-8.
2010: Angelo M Carella; Anna Garuti; Gabriella Cirmena; Gioacchino Catania; Ilaria Rocco; Claudia Palermo; Gianmatteo Pica; Ivana Pierri; Maurizio Miglino; Alberto Ballestrero; marco gobbi; Franco Patrone
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia.
Leukemia & lymphoma 2010;51(2):275-8.
2009: Francesco Forconi; Elisa Sozzi; Emanuele Cencini; Francesco Zaja; Tamara Intermesoli; Caterina Stelitano; Luigi Rigacci; Filippo Gherlinzoni; Renato Cantaffa; Anna Baraldi; Andrea Gallamini; Alfonso Zaccaria; Alessandro Pulsoni; marco gobbi; Maristella Tassi; Donatella Raspadori; Lorenzo Leoncini; Andrea Rinaldi; Elena Sabattini; Francesco Bertoni; Stefano A Pileri; Francesco Lauria
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.
Blood 2009;114(21):4696-702.
2009: Francesca Olcese; Marino Clavio; Edoardo Rossi; Mauro Spriano; Filippo Ballerini; Letizia Canepa; Ivana Pierri; Sara Aquino; Riccardo Varaldo; Annunziata Manna; Vincenzo Secondo; Omar Racchi; Enrico Balleari; Giulio Fraternali Orcioni; Angelo Michele Carella; Riccardo Ghio; marco gobbi
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
Annals of hematology 2009;88(9):855-61.
2009: Maria Teresa Voso; Valeria Santini; Carlo Finelli; Pellegrino Musto; Enrico Pogliani; Emanuele Angelucci; Giuseppe Fioritoni; Giuliana Alimena; Luca Maurillo; Agostino Cortelezzi; Francesco Buccisano; marco gobbi; Lorenza Borin; Anna Di Tucci; Gina Zini; Maria Concetta Petti; Giovanni Martinelli; Emiliano Fabiani; Paola Fazi; Marco Vignetti; Alfonso Piciocchi; Vincenzo Liso; Sergio Amadori; Giuseppe Leone
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):5002-7.
2009: Michele Cea; Gabriele Zoppoli; Santina Bruzzone; Floriana Fruscione; Eva Moran; Anna Garuti; Ilaria Rocco; Gabriella Cirmena; Salvatore Casciaro; Francesca Olcese; Ivana Pierri; Antonia Cagnetta; Fabio Ferrando; Riccardo Ghio; marco gobbi; Alberto Ballestrero; Franco Patrone; Alessio Nencioni
APO866 activity in hematologic malignancies: a preclinical in vitro study.
Blood 2009;113(23):6035-7; author reply 6037-8.
2009: Matteo Bassetti; Ernestina Repetto; Malgorzata Mikulska; M Miglino; M Clavio; marco gobbi; Elda Righi; Claudio Viscoli
Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
Journal of chemotherapy (Florence, Italy) 2009;21(2):211-4.
2009: Marino Clavio; Anna Ghiso; Chiara Ghiggi; Mauro Spriano; Nicoletta Colombo; Raffaella Grasso; Riccardo Varaldo; Maurizio Miglino; Ivana Pierri; Francesca Olcese; Sara Aquino; Samantha Biasco; Enrico Balleari; Angelo Michele Carella; Mario Sessarego; marco gobbi
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa.
Oncology reports 2009;21(4):1045-52.
2009: A Poggi; S Catellani; A Garuti; I Pierri; marco gobbi; M R Zocchi
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate.
Leukemia 2009;23(4):641-8.
2008: Michele Malagola; Annalisa Peli; Daniela Damiani; Anna Candoni; Mario Tiribelli; giovanni martinelli; Pier Paolo Piccaluga; Stefania Paolini; Francesco De Rosa; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Eliana Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Maria Roccaro; Carla Filì; Renato Fanin; Michele Baccarani; Domenico Russo
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
European journal of haematology 2008;81(5):354-63.
2008: Francesco Frassoni; Francesca Gualandi; Marina Podestà; Anna Maria Raiola; Adalberto Ibatici; Giovanna Piaggio; Mario Sessarego; Nadia Sessarego; marco gobbi; Nicoletta Sacchi; Myriam Labopin; Andrea Bacigalupo
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
The lancet oncology 2008;9(9):831-9.
2008: Luana Benedetti; Diego Franciotta; Alessandro Beronio; Luigi Cadenotti; marco gobbi; Giovanni Luigi Mancardi; Angelo Schenone; Antonio Tartaglione
Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.
Muscle & nerve 2008;38(2):1076-7.
2008: E Righi; C G Giacomazzi; V Lindstrom; Alessandra Albarello; Ornella Soro; M Miglino; M Perotti; Oliviero Varnier; marco gobbi; Claudio Viscoli; Matteo Bassetti
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies.
Mycopathologia 2008;165(6):407-10.
2008: Alessandro Poggi; Silvia Catellani; A Bruzzone; Federico Caligaris-Cappio; marco gobbi; Maria Raffaella Zocchi
Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division.
Leukemia 2008;22(5):980-8.
2008: Pier Luigi Zinzani; Monica Tani; Alessandro Pulsoni; marco gobbi; Alessio Perotti; Stefano De Luca; Alberto Fabbri; Alfonso Zaccaria; Maria Teresa Voso; Patrizia Fattori; Luciano Guardigni; Sonia Ronconi; Maria Giuseppina Cabras; Luigi Rigacci; Amalia De Renzo; Enrica Marchi; Vittorio Stefoni; Mariapaola Fina; Cinzia Pellegrini; Gerardo Musuraca; Enrico Derenzini; Stefano Pileri; Stefano Fanti; Pier Paolo Piccaluga; Michele Baccarani
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
The lancet oncology 2008;9(4):352-8.
2008: Philipp le Coutre; Oliver G Ottmann; Francis Giles; Dong-Wook Kim; Jorge Cortes; Norbert Gattermann; Jane F Apperley; Richard A Larson; Elisabetta Abruzzese; Stephen G O'Brien; Kazimierz Kuliczkowski; Andreas Hochhaus; Francois-Xavier Mahon; Giuseppe Saglio; marco gobbi; Yok-Lam Kwong; Michele Baccarani; Timothy Hughes; giovanni martinelli; Jerald P Radich; Ming Zheng; Yaping Shou; Andrew Lamb
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
Blood 2008;111(4):1834-9.
2008: Daniela de Totero; Raffaella Meazza; Matteo Capaia; Marina Fabbi; Bruno Azzarone; Enrico Balleari; marco gobbi; Giovanna Cutrona; Manlio Ferrarini; Silvano Ferrini
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
Blood 2008;111(2):517-24.
2008: Alberto Ballestrero; Davide Boy; Roberta Gonella; Maurizio Miglino; Marino Clavio; Valentina Barbero; Alessio Nencioni; marco gobbi; Franco Patrone
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas.
Annals of hematology 2008;87(1):49-55.
2007: Danielly Vicente; Teresa Lamparelli; Francesca Gualandi; Domenico Occhini; Anna Maria Raiola; Adalberto Ibatici; Maria Teresa Van Lint; marco gobbi; Maurizio Miglino; Marino Clavio; Marco Risso; Francesco Frassoni; Andrea Bacigalupo
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.
Bone marrow transplantation 2007;40(4):349-54.
2007: Marino Clavio; Luana Vignolo; Alessandra Albarello; Riccardo Varaldo; Ivana Pierri; Gioacchino Catania; Manuela Balocco; Gian Luca Michelis; Maurizio Miglino; Annunziata Manna; Enrico Balleari; Angelo Michele Carella; Mario Sessarego; Maria Teresa Van Lint; Andrea Bacigalupo; marco gobbi
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
British journal of haematology 2007;138(2):186-95.
2007: Luana Benedetti; Chiara Briani; Marina Grandis; Tiziana Vigo; marco gobbi; Elisabetta Ghiglione; Marinella Carpo; Dario Cocito; Christina M Caporale; Maria Pia Sormani; Giovanni Luigi Mancardi; Eduardo Nobile-Orazio; Angelo Schenone
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M.
Journal of the peripheral nervous system : JPNS 2007;12(2):102-7.
2007: Alida Dominietto; Sarah Pozzi; Maurizio Miglino; Flavio Albarracin; Giovanna Piaggio; Francesca Bertolotti; Raffaella Grasso; Simona Zupo; Anna Maria Raiola; marco gobbi; Francesco Frassoni; Andrea Bacigalupo
Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia.
Blood 2007;109(11):5063-4.
2007: Silvia Catellani; Alessandro Poggi; Andrea Bruzzone; Patrizia Dadati; Jean Louis Ravetti; marco gobbi; Maria Raffaella Zocchi
Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins.
Blood 2007;109(5):2078-85.
2007: Stefania Laurent; Giulio L Palmisano; Alberto M Martelli; Tomohiro Kato; Pier Luigi Tazzari; Ivana Pierri; Marino Clavio; Beatrice Dozin; Giuseppe Balbi; Mauro Megna; Anna Morabito; Teresa Lamparelli; Andrea Bacigalupo; marco gobbi; Maria Pia Pistillo
CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis.
British journal of haematology 2007;136(4):597-608.
2007: Michele Malagola; Daniela Damiani; giovanni martinelli; Angela Michelutti; Bruno Cesana; Antonio De Vivo; Pier Paolo Piccaluga; Emanuela Ottaviani; Anna Candoni; Antonella Geromin; Mario Tiribelli; Renato Fanin; Nicoletta Testoni; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Elisa Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Roccaro; Carla Filí; Michele Baccarani; Domenico Russo
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 2007;136(1):87-95.
2006: Maurizio Miglino; Riccardo Varaldo; Nicoletta Colombo; Raffaella Grasso; Marino Clavio; Anna Garuti; S Aquino; Alessandra Albarello; Mario Sessarego; marco gobbi
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases.
Journal of experimental & clinical cancer research : CR 2006;25(3):321-4.
2006: Maurizio Miglino; Raffaella Grasso; Riccardo Varaldo; Giuseppina Fugazza; Nicoletta Colombo; Marino Clavio; Letizia Canepa; Anna Garuti; Adalberto Ibatici; Ivana Pierri; Filippo Ballerini; Mario Sessarego; marco gobbi
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia.
Leukemia & lymphoma 2006;47(7):1348-51.
2006: Daniela de Totero; Raffaella Meazza; Simona Zupo; Giovanna Cutrona; Serena Matis; Monica Colombo; Enrico Balleari; Ivana Pierri; Marina Fabbi; Matteo Capaia; Bruno Azzarone; marco gobbi; Manlio Ferrarini; Silvano Ferrini
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
Blood 2006;107(9):3708-15.
2006: Enrico Balleari; Edoardo Rossi; Marino Clavio; Angela Congiu; marco gobbi; Marco Grosso; Vincenzo Secondo; Mauro Spriano; Silvana Timitilli; Riccardo Ghio
Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Annals of hematology 2006;85(3):174-80.
2006: Ilaria Iacobucci; Gianantonio Rosti; Marilina Amabile; Angela Poerio; Simona Soverini; Daniela Cilloni; Nicoletta Testoni; Elisabetta Abruzzese; Enrico Montefusco; Emanuela Ottaviani; Franco Iuliano; Domenico Russo; marco gobbi; Giuliana Alimena; Bruno Martino; Carolina Terragna; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):454-9.
2005: Alessandro Poggi; Claudia Prevosto; Anna-Maria Massaro; Simone Negrini; Serena Urbani; Ivana Pierri; Riccardo Saccardi; marco gobbi; Maria Raffaella Zocchi
Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):6352-60.
2005: Marino Clavio; Alberto Garrone; Ivana Pierri; Gian Luca Michelis; Manuela Balocco; Alessandra Albarello; Riccardo Varaldo; Paolo Canepa; Maurizio Miglino; Filippo Ballerini; Letizia Canepa; marco gobbi
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Oncology reports 2005;14(4):933-40.
2005: Giuseppe Villa; Enrico Balleari; Marco Carletto; Marco Grosso; Marino Clavio; Arnoldo Piccardo; L Rebella; Luigi Tommasi; Silvia Morbelli; F Peschiera; marco gobbi; Riccardo Ghio
Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Journal of experimental & clinical cancer research : CR 2005;24(3):355-61.
2005: Riccardo Varaldo; marco gobbi
[Moschkowitz's disease].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 2005;20(2):69-70.
2005: Marino Clavio; Enrico Balleari; Alberto Garrone; Filippo Ballerini; Riccardo Varaldo; Gian Luca Michelis; Manuela Balocco; N Abdall; Nicoletta Colombo; Raffaella Grasso; marco gobbi
Haemopoietic growth factors in myelodysplastic syndromes: towards patient-oriented therapy?
Journal of experimental & clinical cancer research : CR 2005;24(1):5-16.
2004: Alessandro Poggi; Claudia Venturino; Silvia Catellani; Marino Clavio; Maurizio Miglino; marco gobbi; Alexander Steinle; Paolo Ghia; Stefania Stella; Federico Caligaris-Cappio; Maria Raffaella Zocchi
Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Cancer research 2004;64(24):9172-9.
2004: R Franceschini; F Zoppi; A Garuti; marco gobbi
The role of alpha-interferon in chronic myelogenous leukaemia in Imatinib era.
Journal of experimental & clinical cancer research : CR 2004;23(4):697-8.
2004: Marino Clavio; Ivana Pierri; Claudia Venturino; Alberto Garrone; Letizia Canepa; Maurizio Miglino; Riccardo Varaldo; Filippo Ballerini; Gian Luca Michelis; Manuela Balocco; Nabila Abdall; Simona Gatto; marco gobbi
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.
Leukemia & lymphoma 2004;45(12):2527-30.
2004: Marino Clavio; Claudia Venturino; Ivana Pierri; Alberto Garrone; Maurizio Miglino; Letizia Canepa; Enrico Balleari; Manuela Balocco; Gian Luca Michelis; Filippo Ballerini; marco gobbi
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Annals of hematology 2004;83(11):696-703.
2004: Pier Luigi Zinzani; Alessandro Pulsoni; Alessio Perrotti; Simona Soverini; Francesco Zaja; Amalia De Renzo; Sergio Storti; Vito Michele Lauta; Luciano Guardigni; Paolo Gentilini; Alessandra Tucci; Anna Lia Molinari; marco gobbi; Brunangelo Falini; Patrizia Fattori; Fabrizio Ciccone; Lapo Alinari; Maurizio Martelli; Stefano Pileri; Sante Tura; Michele Baccarani
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2654-61.
2004: Giuseppina Fugazza; Maurizio Miglino; Roberto Bruzzone; S Quintino; A M Gatti; Raffaella Grasso; marco gobbi; Francesco Frassoni; Mario Sessarego
Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
Journal of experimental & clinical cancer research : CR 2004;23(2):295-9.
2004: Marino Clavio; Flavio Nobili; Enrico Balleari; Nicola Girtler; Filippo Ballerini; Paolo Vitali; Paola Rosati; Claudia Venturino; Riccardo Varaldo; marco gobbi; Riccardo Ghio; Guido Rodriguez
Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report.
European journal of haematology 2004;72(2):113-20.
2004: Daniela de Totero; Mariapina Montera; Ombretta Rosso; Marino Clavio; Enrico Balleari; Robin Foa; marco gobbi
Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):152-60.
2003: Riccardo Varaldo; marco gobbi
[Pharmacologic characteristics and clinical activity of human rituximab anti-CD20 monoclonal antibody].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 2003;18(3):182-7.
2003: Giuseppe Murdaca; Maurizio Setti; Giuseppe Cittadini; Gabriella Gentile; Andrea Menin; Roberto Fiocca; marco gobbi; Francesco Puppo; Francesco Indiveri
[Mediastinal syndrome: clinical presentation of lymphoma. Report of a case of Hodgkin's lymphoma and a case of non-Hodgkin's lymphoma with similar presentation].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 2003;18(3):170-81.
2003: Franco Mandelli; Roberto Latagliata; Giuseppe Avvisati; Paola Fazi; Francesco Rodeghiero; Franco Leoni; marco gobbi; Francesco Nobile; Eugenio Gallo; R Fanin; Sergio Amadori; Marco Vignetti; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Rosario Giustolisi; Giorgio Broccia; Maria Concetta Petti; Francesco Lo Coco
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
Leukemia 2003;17(6):1085-90.
2003: Daniela de Totero; Pier Luigi Tazzari; Matteo Capaia; Mariapina Montera; Marino Clavio; Enrico Balleari; Robin Foa; marco gobbi
CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
Haematologica 2003;88(2):148-58.
2003: Giancarlo Caletti; Thomas Togliani; Pietro Fusaroli; Elena Sabattini; Edna Khodadadian; Barbara Gamberi; marco gobbi; Stefano Pileri
Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Gastroenterology 2003;124(2):537-43.
2003: Maria Pia Pistillo; Pier Luigi Tazzari; Giulio L Palmisano; Ivana Pierri; Andrea Bolognesi; Francesca Ferlito; Paolo Capanni; Letizia Polito; Marina Ratta; Stefano Pileri; Milena Piccioli; Giuseppe Basso; Laura Rissotto; Roberto Conte; marco gobbi; Fiorenzo Stirpe; Giovanni Battista Ferrara
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells.
Blood 2003;101(1):202-9.
2002: Marino Clavio; Simona Gatto; Germana Beltrami; S Quintino; Letizia Canepa; Ivana Pierri; V Galbusera; P Carrara; Maurizio Miglino; Riccardo Varaldo; Filippo Ballerini; Claudia Venturino; Raffaella Cerri; Marco Risso; Enrico Balleari; Angelo Michele Carella; Mario Sessarego; Riccardo Ghio; Andrea Bacigalupo; marco gobbi
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.
Journal of experimental & clinical cancer research : CR 2002;21(4):481-7.
2002: Maurizio Miglino; Giovanni Berisso; Raffaella Grasso; Letizia Canepa; Marino Clavio; Ivana Pierri; D Pietrasanta; Simona Gatto; Riccardo Varaldo; Filippo Ballerini; Simonetta Verdiani; Lucia Casarino; F DeStefano; Mario Sessarego; Alida Dominietto; Anna Maria Raiola; Stefania Bregante; Carmen Di Grazia; marco gobbi; Andrea Bacigalupo
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Bone marrow transplantation 2002;30(9):579-85.
2002: Franco Bonanni; Marcello Brignone; Alberto Garrone; marco gobbi; Giorgio Menardo; Lionello Parodi; Carlo Venzano
AMIL survey (anemia in Internal Medicine in Liguria).
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 2002;17(4):248-51.
2002: Domenico Russo; Pier Paolo Piccaluga; Mariagrazia Michieli; Teresa Michelutti; Giuseppe Visani; Luigi Gugliotta; Alessandro Bonini; Ivana Pierri; marco gobbi; Mario Tiribelli; Renato Fanin; S Piccolrovazzi; Michele Baccarani
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
Annals of hematology 2002;81(8):462-6.
2002: Paolo Torelli; Davide Cavaliere; Marco Casaccia; Fabrizio Panaro; P Grondona; Edoardo Rossi; Gino Santini; Mauro Truini; marco gobbi; Andrea Bacigalupo; Umberto Valente
Laparoscopic splenectomy for hematological diseases.
Surgical endoscopy 2002;16(6):965-71.
2002: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Sonia Ronconi; Francesca Patriarca; Filippo Ballerini; Pellegrino Musto; Francesco Di Raimondo; Antonio Ledda; Francesco Lauria; Luciano Masini; marco gobbi; Angelo Vacca; Roberto Ria; Delia Cangini; Sante Tura; Michele Baccarani; Michele Cavo
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
Haematologica 2002;87(4):408-14.
2002: Alberto Ballestrero; Fabio Ferrando; Maurizio Miglino; Marino Clavio; Roberta Gonella; Anna Garuti; Raffaella Grasso; Riccardo Ghio; Enrico Balleari; marco gobbi; Franco Patrone
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma.
European journal of haematology 2002;68(2):101-6.
2001: Maria Raffaella Zocchi; Fabio Pellegatta; Ivana Pierri; marco gobbi; Alessandro Poggi
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells.
European journal of immunology 2001;31(12):3667-75.
2001: Letizia Canepa; Filippo Ballerini; Riccardo Varaldo; S Quintino; L Reni; Marino Clavio; Maurizio Miglino; Ivana Pierri; marco gobbi
Thalidomide in agnogenic and secondary myelofibrosis.
British journal of haematology 2001;115(2):313-5.
2001: Marino Clavio; S Quintino; Claudia Venturino; Filippo Ballerini; Riccardo Varaldo; Simona Gatto; V Galbusera; Alberto Garrone; Raffaella Grasso; Letizia Canepa; Maurizio Miglino; Ivana Pierri; marco gobbi
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
Journal of experimental & clinical cancer research : CR 2001;20(3):351-8.
2001: Maurizio Miglino; Gino Santini; Raffaella Grasso; D Pietrasanta; Marino Clavio; Ivana Pierri; Letizia Canepa; Sandro Nati; Filippo Ballerini; Riccardo Varaldo; Giulio L Palmisano; marco gobbi
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation.
Haematologica 2001;86(7):706-14.
2001: Marino Clavio; S Quintino; B Masoudi; S Carrara; Raffaella Cerri; Ivana Pierri; Letizia Canepa; Maurizio Miglino; P Muner; Eugenio E Damasio; marco gobbi
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens.
Journal of experimental & clinical cancer research : CR 2001;20(2):165-73.
2001: Giuseppe Visani; P Bernasconi; M Boni; G L Castoldi; Stefania Ciolli; Marino Clavio; m christina cox; A Cuneo; Giovanni Del Poeta; D Dini; Daniela Falzetti; Renato Fanin; marco gobbi; Alessandro Isidori; Franco Leoni; V Liso; Michele Malagola; giovanni martinelli; Cristina Mecucci; Pier Paolo Piccaluga; Maria Concetta Petti; Roberto Rondelli; Domenico Russo; Mario Sessarego; Giorgina Specchia; Nicoletta Testoni; G Torelli; Franco Mandelli; Sante Tura
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Leukemia 2001;15(6):903-9.
2001: Maurizio Miglino; Raffaella Grasso; D Pietrasanta; Giulio L Palmisano; Giovanni Berisso; Marino Clavio; Ivana Pierri; Gino Santini; Letizia Canepa; marco gobbi
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
Journal of experimental & clinical cancer research : CR 2001;20(1):95-101.
2001: Gino Santini; Sandro Nati; Mauro Spriano; Andrea Gallamini; D Pierluigi; Angela Congiu; Mauro Truini; Alessandra Rubagotti; Teodoro Chisesi; Renato Vimercati; Edoardo Rossi; Mario Roberto Sertoli; Daniele Mattei; Gennaro Marino; marco gobbi
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Haematologica 2001;86(3):282-6.
2001: Pier Luigi Zinzani; Maurizio Martelli; Maurizio Bendandi; Amalia De Renzo; Alfonso Zaccaria; E Pavone; Monica Bocchia; Brunangelo Falini; marco gobbi; Filippo Gherlinzoni; Vittorio Stefoni; Monica Tani; Sante Tura
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Haematologica 2001;86(2):187-91.
2001: Domenico Russo; Giancarla Pricolo; Mariagrazia Michieli; Angela Michelutti; Donatella Raspadori; A Bertone; Luciana Marin; Ivana Pierri; Alessandro Bucalossi; Elisa Zuffa; Antonio de Vivo; Patrizio Mazza; marco gobbi; Francesco Lauria; Alfonso Zaccaria; Michele Baccarani
Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Leukemia & lymphoma 2001;40(3-4):335-43.
2001: Marino Clavio; Simona Gatto; Germana Beltrami; Raffaella Cerri; P Carrara; Ivana Pierri; Letizia Canepa; Maurizio Miglino; Enrico Balleari; B Masoudi; Eugenio E Damasio; Riccardo Ghio; Mario Sessarego; marco gobbi
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia.
Leukemia & lymphoma 2001;40(3-4):305-13.
2001: Enrico Balleari; Giuseppe Villa; S Garrè; P Ghirlanda; G Agnese; Marco Carletto; Marino Clavio; Fabio Ferrando; marco gobbi; Giuliano Mariani; Riccardo Ghio
Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Haematologica 2001;86(1):78-84.
2000: Alberto Ballestrero; Marino Clavio; Fabio Ferrando; Roberta Gonella; Anna Garuti; Mario Sessarego; Riccardo Ghio; marco gobbi; Franco Patrone
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma.
International journal of oncology 2000;17(5):1007-13.
2000: Pier Luigi Zinzani; M Magagnoli; Luciano Moretti; Amalia De Renzo; R Battista; Alfonso Zaccaria; Luciano Guardigni; Patrizio Mazza; R Marra; F Ronconi; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; Paolo Gentilini; Fabrizio Ciccone; Claudia Cellini; Vittorio Stefoni; F Ricciuti; marco gobbi; Sante Tura
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):773-9.
2000: Eugenio E Damasio; Marino Clavio; B Masoudi; A Isaza; Mauro Spriano; Edoardo Rossi; Salvatore Casciaro; Raffaella Cerri; Marco Risso; Sandro Nati; M Siccardi; Mauro Truini; marco gobbi
Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis.
European journal of haematology 2000;64(1):47-52.
1999: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Francesco Zaja; Sergio Storti; E Pavone; Vito Michele Lauta; Amalia De Renzo; marco gobbi; Monica Bocchia; F Ronconi; Laura Scaramucci; Filippo Gherlinzoni; Fioretta Palombi; Maurizio Bendandi; Vittorio Stefoni; P Anticoli Borza; Claudia Cellini; Franco Mandelli; Sante Tura
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Haematologica 1999;84(11):996-1001.
1999: Pier Luigi Tazzari; Daniela de Totero; Andrea Bolognesi; N Testoni; S Pileri; silvio Roncella; Gigliola Reato; H Stein; marco gobbi; F Stirpe
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.
Haematologica 1999;84(11):988-95.
1999: Pier Luigi Zinzani; Sergio Storti; Alfonso Zaccaria; Luciano Moretti; M Magagnoli; E Pavone; Paolo Gentilini; Luciano Guardigni; marco gobbi; Patrizia Fattori; Brunangelo Falini; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; Amalia De Renzo; Francesco Zaja; Patrizio Mazza; Ettore Volpe; Monica Bocchia; E Aitini; Michela Tabanelli; Giuseppe Leone; Sante Tura
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.
Blood 1999;94(1):33-8.
1999: Ivana Pierri; Marino Clavio; Maurizio Miglino; Marina Cavaliere; D Pietrasanta; marco gobbi
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly.
Haematologica 1999;84(6):562-3.
1999: Marino Clavio; B Masoudi; Mauro Spriano; Salvatore Casciaro; marco gobbi; Eugenio E Damasio
Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
Haematologica 1999;84(5):466-8.
1999: Alberto Ballestrero; Fabio Ferrando; Anna Garuti; P Basta; Roberta Gonella; P Stura; Giuseppe Sandro Mela; Mario Sessarego; marco gobbi; Franco Patrone
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1296.
1999: Ivana Pierri; Marino Clavio; Germana Beltrami; Marina Cavaliere; Luca Lanza; Maurizio Miglino; Letizia Canepa; D Pietrasanta; Filippo Ballerini; S Quintino; Simona Gatto; L Celesti; P Carrara; P Varese; marco gobbi
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly.
Journal of experimental & clinical cancer research : CR 1999;18(1):55-60.
1999: Daniela de Totero; Gigliola Reato; Francesca Romana Mauro; Alessandro Cignetti; Silvano Ferrini; Anna Guarini; marco gobbi; C E Grossi; Robin Foa
IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia.
British journal of haematology 1999;104(3):589-99.
1998: Mario Sessarego; Giuseppina Fugazza; marco gobbi; Roberto Bruzzone; R Bisio; Riccardo Ghio; Franco Patrone
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1998;106(2):110-5.
1998: Marino Clavio; Maurizio Miglino; Mauro Spriano; D Pietrasanta; E Vallebella; L Celesti; Letizia Canepa; Ivana Pierri; Marina Cavaliere; Filippo Ballerini; Germana Beltrami; Edoardo Rossi; Renato Vimercati; R Bruni; M Congiu; Sandro Nati; Eugenio E Damasio; Gino Santini; marco gobbi
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.
European journal of haematology 1998;61(3):197-203.
1998: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Alfonso Zaccaria; F Ronconi; Maria Cantonetti; Monica Bocchia; R Marra; marco gobbi; Brunangelo Falini; Filippo Gherlinzoni; Luciano Moretti; Amalia De Renzo; Patrizio Mazza; E Pavone; Elena Sabattini; A Amendola; Maurizio Bendandi; Stefano A Pileri; Franco Mandelli; Sante Tura
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Blood 1998;92(3):790-4.
1997: Gino Santini; Angela Congiu; Sandro Nati; Letizia Canepa; Mauro Spriano; Teodoro Chisesi; Edoardo Rossi; Renato Vimercati; Mario Roberto Sertoli; Osvaldo Figari; marco gobbi; Giovanna Piaggio; F Vassallo; Federica Benvenuto; Monica Soracco; Maurizio Miglino; Jean Louis Ravetti; Mauro Truini
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.
Leukemia & lymphoma 1997;26 Suppl 1():83-8.
1997: D Pietrasanta; Marino Clavio; E Vallebella; Germana Beltrami; Marina Cavaliere; marco gobbi
Long-lasting effect of cyclosporin-A on anemia associated with idiopathic myelofibrosis.
Haematologica 1997;82(4):458-9.
1997: Pier Luigi Zinzani; E Pavone; Sergio Storti; Luciano Moretti; Patrizia Fattori; Luciano Guardigni; Brunangelo Falini; marco gobbi; Paolo Gentilini; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; M Magagnoli; Silvia Venturi; E Aitini; Michela Tabanelli; Giuseppe Leone; V Liso; Sante Tura
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.
Blood 1997;89(11):3974-9.
1997: L Celesti; Marino Clavio; Alessandro Poggi; Salvatore Casciaro; E Vallebella; marco gobbi
The association of cyclophosphamide and dexamethasone in advanced refractory multiple myeloma patients.
Haematologica 1997;82(3):351-3.
1996: Marino Clavio; P Carrara; Maurizio Miglino; Ivana Pierri; Letizia Canepa; Enrico Balleari; A M Gatti; R Cerri; L Celesti; E Vallebella; Mario Sessarego; Franco Patrone; Riccardo Ghio; Eugenio E Damasio; marco gobbi
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia.
Haematologica 1996;81(6):513-20.
1996: Marino Clavio; Edoardo Rossi; Mauro Truini; P Carrara; Jean Louis Ravetti; Mauro Spriano; A R Vimercati; Gino Santini; Letizia Canepa; Ivana Pierri; L Celesti; Maurizio Miglino; A Castellaneta; Eugenio E Damasio; marco gobbi
Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients.
Leukemia & lymphoma 1996;22(3-4):319-27.
1996: Gino Santini; Angela Congiu; Sandro Nati; D Pierluigi; Mauro Spriano; Teodoro Chisesi; Edoardo Rossi; Renato Vimercati; Mario Roberto Sertoli; Osvaldo Figari; marco gobbi; Giovanna Piaggio; F Vassallo; Federica Benvenuto; Monica Soracco; Maurizio Miglino; R Bruni; Jean Louis Ravetti; Mauro Truini
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.
Leukemia 1996;10 Suppl 2():s88-91.
1996: Marino Clavio; Salvatore Casciaro; A M Gatti; Mauro Spriano; F Bonanni; A Poggi; E Vallebella; D Pietrasanta; E Prencipe; R Goretti; Renato Vimercati; Edoardo Rossi; B Masoudi; Riccardo Ghio; P Boccaccio; S Ricciardi; Eugenio E Damasio; marco gobbi
Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients.
Haematologica 1996;81(3):238-44.
1996: Giuseppe Visani; Patrizia Tosi; Pier Luigi Zinzani; Silvia Manfroi; Emanuela Ottaviani; A Cenacchi; P Carrara; Marino Clavio; marco gobbi; Sante Tura
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects.
European journal of haematology 1996;56(5):308-12.
1996: Giacomo Borgonovo; V Secondo; Emanuela Varaldo; Vito Pistoia; marco gobbi; Francesca Mattioli
Large granular lymphocyte leukemia associated with hepatocellular carcinoma: a case report.
Haematologica 1996;81(2):172-4.
1995: Pier Luigi Tazzari; Francesca Ricci; Nicola Vianelli; Cristina Tassi; D Belletti; I Pierri; L Gugliotta; marco gobbi; Roberto Conte
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders.
Annals of hematology 1995;70(5):267-72.
1995: Franco Patrone; Alberto Ballestrero; Fabio Ferrando; Fulvio Brema; L Moraglio; M Valbonesi; P Basta; Riccardo Ghio; marco gobbi; Mario Sessarego
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):840-6.
1995: Giuseppina Fugazza; Roberto Bruzzone; A M Dejana; marco gobbi; Riccardo Ghio; Franco Patrone; S Rattenni; Mario Sessarego
Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization.
Leukemia 1995;9(1):109-14.
1994: Enrico Balleari; Caterina Bason; G Visani; marco gobbi; E Ottaviani; Riccardo Ghio
Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Haematologica 1994;79(1):7-12.
1993: Maurizio Miglino; Ivana Pierri; Letizia Canepa; P Carrara; L Celesti; marco gobbi
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma.
Haematologica 1993;78(6):411-3.
1993: Daniela de Totero; Pier Luigi Tazzari; Francesco Lauria; Donatella Raspadori; P F di Celle; A Carbone; marco gobbi; Robin Foa
Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25).
Blood 1993;82(2):528-35.
1993: marco gobbi; Marco Scudeletti
Deflazacort in the treatment of haematologic disorders.
European journal of clinical pharmacology 1993;45 Suppl 1():S25-8.
1992: Daniela de Totero; Pier Luigi Tazzari; J P DiSanto; P F di Celle; Donatella Raspadori; Roberto Conte; marco gobbi; Giovanni Battista Ferrara; N Flomenberg; Francesco Lauria
Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains.
Blood 1992;80(7):1765-73.
1992: Andrea Bolognesi; Pier Luigi Tazzari; Cristina Tassi; G Gromo; marco gobbi; Fiorenzo Stirpe
A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.
Clinical and experimental immunology 1992;89(3):341-6.
1992: Pier Luigi Tazzari; Andrea Bolognesi; Daniela de Totero; S Pileri; Roberto Conte; J Wijdenes; P Hervé; Marco Soria; Fiorenzo Stirpe; marco gobbi
B-B10 (anti-CD25)-saporin immunotoxin--a possible tool in graft-versus-host disease treatment.
Transplantation 1992;54(2):351-6.
1992: Pier Luigi Tazzari; Andrea Bolognesi; Daniela de Totero; B Falini; R M Lemoli; Marco Soria; S Pileri; marco gobbi; Harald Stein; L Flenghi
Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.
British journal of haematology 1992;81(2):203-11.
1992: F Puppo; M Scudeletti; L Murgia; R Ruzzenenti; Maurizio Setti; I Ponassi; marco gobbi; F Indiveri
Acute myelomonocytic leukaemia in an HIV-infected patient.
AIDS (London, England) 1992;6(1):136-7.
1991: S A Pileri; Elena Sabattini; Brunangelo Falini; Pier Luigi Tazzari; Filippo Gherlinzoni; Mariagrazia Michieli; D Damiani; L Zucchini; marco gobbi; T Tsuruo
Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas.
Histopathology 1991;19(2):131-40.
1991: S Pileri; Elena Sabattini; Pier Luigi Tazzari; marco gobbi; Filippo Gherlinzoni; Brunangelo Falini; Michele Baccarani
[Immunohistochemical determination of glycoprotein P in 60 non-Hodgkin's lymphomas].
Haematologica 1991;76 Suppl 3():158-61.
1991: marco gobbi; Mariagrazia Michieli; Donatella Raspadori; Daniela Damiani; Angela Michelutti; I Pierri; P L Tazzari
[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)].
Haematologica 1991;76 Suppl 3():150-3.
1991: Cristina Tassi; A Fortuna; Andrea Bontadini; Roberto M Lemoli; marco gobbi; Pier Luigi Tazzari
CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.
Haematologica 1991;76 Suppl 1():41-3.
1991: marco gobbi; P L Tazzari; M Cavo; C Tassi; M Grimaldi; G Meloni; G Di Nucci; M Vignetti; Andrea Bolognesi; F Stirpe
Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Bone marrow transplantation 1991;7 Suppl 2():30.
1990: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; R Zanchini; Monica Bocchia; E Aitini; Giovanna Cavazzini; B Amurri; marco gobbi; Sante Tura
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Tumori 1990;76(6):533-6.
1990: A Dinota; Pier Luigi Tazzari; Mariagrazia Michieli; Giuseppe Visani; marco gobbi; Andrea Bontadini; Cristina Tassi; R Fanin; Daniela Damiani; M Grandi
In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
Cancer research 1990;50(14):4291-4.
1990: A Dinota; Pier Luigi Tazzari; A Abbondanza; Maria Giulia Battelli; marco gobbi; Fiorenzo Stirpe
Bone marrow purging by a xanthine oxidase-antibody conjugate.
Bone marrow transplantation 1990;6(1):31-6.
1990: A Dinota; Pier Luigi Tazzari; Andrea Bontadini; Donatella Raspadori; Cristina Tassi; L Zucchini; M Pizzuti; F Ricciuti; marco gobbi
Evaluation of LAK-mediated tumor cell killing in a plasma clot clonogenic assay.
Haematologica 1990;75(4):323-6.
1990: G Saglio; R Foá; Angelo Guerrasio; P F di Celle; Giorgio Palestro; A Sinicco; marco gobbi; F Gavosto
Immunoglobulin and Myc gene structure in lymphnode biopsies from HIV-positive patients with LAS and lymphoma.
Cancer detection and prevention 1990;14(3):359-62.
1990: G D Di Nucci; Pier Luigi Tazzari; Andrea Bontadini; Cristina Tassi; A Dinota; S Pileri; marco gobbi
Improved methods for the determination of 5-bromo-2-deoxyuridine labelling index in clones and colonies growing in plasma clots.
Basic and applied histochemistry 1990;34(1):71-7.
1990: Andrea Bontadini; Roberto Conte; A Dinota; D Belletti; Cristina Tassi; Pier Luigi Tazzari; marco gobbi
Mixed lymphocyte reactions evaluated by means of bromodeoxyuridine incorporation.
Haematologica 1990;75(1):7-11.
1990: MS Gilardini Montani; F Del Gallo; marco gobbi; Giovanna Lombardi; Enza Piccolella; Orsola Pugliese; Vittorio Colizzi
Regulation of self-major histocompatibility complex reactive human T-cell clones.
International journal of immunopharmacology 1990;12(3):255-60.
1989: Sante Tura; Michele Cavo; Gianantonio Rosti; Giuseppe Bandini; marco gobbi; M Grimaldi; M C Miggiano; L Albertazzi; M A Bonelli
Allogeneic bone marrow transplantation for multiple myeloma.
Bone marrow transplantation 1989;4 Suppl 4():106-8.
1989: G Visani; R M Lemoli; A Dinota; Piero Galieni; marco gobbi; Michele Cavo; S Tura
Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferation.
Transplantation 1989;48(6):1026-31.
1989: P L Tazzari; M Cipone; C Tassi; Andrea Bontadini; A M Cremonini; marco gobbi; G Gentile; S Tura
S-phase evaluation with bromodeoxyuridine in lymphocytes from cattle infected with bovine leukemia virus (BLV).
Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B 1989;36(9):691-8.
1989: Michele Cavo; Piero Galieni; Elisa Zuffa; Michele Baccarani; marco gobbi; Sante Tura
Prognostic variables and clinical staging in multiple myeloma.
Blood 1989;74(5):1774-80.
1989: Giuseppe Bandini; Gianantonio Rosti; Michele Cavo; L Albertazzi; Simonetta Rizzi; Maria Rosa Motta; marco gobbi; Cristina Tassi; Pier Luigi Tazzari; C Miggiano
[Allogeneic bone marrow transplantation in multiple myeloma].
Haematologica 1989;74(5 Suppl):463-72.
1989: marco gobbi; S Pileri; N Testoni; P Mazza; A Dinota; S Tura
[New directions in the prognostic evaluation of non-Hodgkin's lymphoma].
Haematologica 1989;74(5 Suppl):392-402.
1989: A Dinota; Luigi Barbieri; marco gobbi; Pier Luigi Tazzari; Simonetta Rizzi; Andrea Bontadini; Andrea Bolognesi; Sante Tura; Fiorenzo Stirpe
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
British journal of cancer 1989;60(3):315-9.
1989: Pier Luigi Tazzari; Maria Giulia Battelli; A Abbondanza; A Dinota; Simonetta Rizzi; marco gobbi; Fiorenzo Stirpe
Targeting of a plasma cell line with a conjugate containing xanthine oxidase and the monoclonal antibody 62B1.
Transplantation 1989;48(1):119-22.
1989: Roberto M Lemoli; Giuseppe Visani; marco gobbi; Simonetta Rizzi; A Dinota; Cristina Tassi; Patrizia Tosi; Piero Galieni; Michele Cavo; Sante Tura
Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT.
Bone marrow transplantation 1989;4(4):373-7.
1989: L Barbieri; A Dinota; marco gobbi; P L Tazzari; Simonetta Rizzi; Andrea Bontadini; Roberto M Lemoli; S Tura; Fiorenzo Stirpe
Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM).
European journal of haematology 1989;42(3):238-45.
1989: Roberto M Lemoli; marco gobbi; Pier Luigi Tazzari; T C Tassi; A Dinota; Giuseppe Visani; G Grassi; P Mazza; Michele Cavo; Sante Tura
Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption.
Transplantation 1989;47(2):385-7.
1989: Michele Cavo; Piero Galieni; M Grimaldi; Elisa Zuffa; M A Bonelli; marco gobbi; Sante Tura
Improvement of Durie & Salmon staging for multiple myeloma by adding platelet count as a stratifying variable: a multivariate regression analysis of 163 untreated patients.
European journal of haematology. Supplementum 1989;51():99-104.
1989: Sante Tura; Michele Cavo; marco gobbi; G Rosti; G Bandini; C Miggiano; L Albertazzi; M Grimaldi; G Visani
High-dose chemoradiotherapy and allogenic bone marrow transplantation in multiple myeloma.
European journal of haematology. Supplementum 1989;51():191-5.
1989: S Pileri; S Poggi; P Baglioni; M Montanari; E Sabattini; Piero Galieni; P L Tazzari; marco gobbi; M Cavo; B Falini
Histology and immunohistology of bone marrow biopsy in multiple myeloma.
European journal of haematology. Supplementum 1989;51():52-9.
1989: marco gobbi; Michele Cavo; Pier Luigi Tazzari; A Dinota; Cristina Tassi; Andrea Bontadini; L Albertazzi; C Miggiano; Simonetta Rizzi; G Rosti
Autologous bone marrow transplantation with immunotoxin-purged marrow for advanced multiple myeloma.
European journal of haematology. Supplementum 1989;51():176-81.
1989: F Stirpe; L Barbieri; P L Tazzari; A Dinota; marco gobbi
Ex vivo bone marrow purging with immunotoxins.
European journal of haematology. Supplementum 1989;51():173-5.
1988: A Dinota; marco gobbi; Pier Luigi Tazzari; Donatella Raspadori; Andrea Bontadini; Francesco Lauria; R Foà; Sante Tura
A sensitive test for the detection of NK activity. Plasma clot clonogenic assay.
Journal of immunological methods 1988;114(1-2):53-9.
1988: Andrea Bontadini; marco gobbi; Pier Luigi Tazzari; Donatella Raspadori; A Dinota; Cristina Tassi; M Buzzi; S Tura
The usefulness of routine immunological monitoring during the remission phase in acute lymphoblastic leukemias.
Haematologica 1988;73(5):359-64.
1988: Maria Giulia Battelli; A Abbondanza; Pier Luigi Tazzari; A Dinota; Simonetta Rizzi; G Grassi; marco gobbi; Fiorenzo Stirpe
Selective cytotoxicity of an oxygen-radical-generating enzyme conjugated to a monoclonal antibody.
Clinical and experimental immunology 1988;73(1):128-33.
1988: Brunangelo Falini; S Canino; S Sacchi; C Ciani; M F Martelli; J Gerdes; H Stein; S Pileri; marco gobbi; M Fagioli
Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies.
British journal of haematology 1988;69(3):311-20.
1988: Roberto Conte; P L Tazzari; G Bandini; G Jemmolo; L Giovanardi; marco gobbi; D Raspadori; A Dinota; P Ricci; R L Powles
Deficiency of autologous mixed lymphocyte reaction in long-term bone marrow transplant recipients without clinical chronic graft versus host disease.
Haematologica 1988;73(4):297-301.
1988: R M Lemoli; marco gobbi; P L Tazzari; G Grassi; A Dinota; F Gherlinzoni; P Mazza; S Tura
Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate.
Haematologica 1988;73(3):183-5.
1988: Daniela Zauli; marco gobbi; C Crespi; Pier Luigi Tazzari; F Miserocchi; A Tassinari
Cytoskeleton organization of normal and neoplastic lymphocytes and lymphoid cell lines of T and B origin.
British journal of haematology 1988;68(4):405-9.
1988: Michele Cavo; Piero Galieni; Cristina Tassi; marco gobbi; Sante Tura
M-2 protocol for melphalan-resistant and relapsing multiple myeloma.
European journal of haematology 1988;40(2):168-73.
1988: U Tirelli; E Vaccher; G Rezza; G Broccia; P G Fassio; marco gobbi; F M Gritti; G Lambertenghi Deliliers; A Lazzarin; G Luzi
Hodgkin disease and infection with the human immunodeficiency virus (HIV) in Italy.
Annals of internal medicine 1988;108(2):309-10.
1988: P L Tazzari; L Barbieri; marco gobbi; A Dinota; Simonetta Rizzi; Andrea Bontadini; A Pession; S Tura; F Stirpe
An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.
Cancer immunology, immunotherapy : CII 1988;26(3):231-6.
1988: Sante Tura; C Finelli; G Bandini; Michele Cavo; marco gobbi
Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia.
Nouvelle revue française d'hématologie 1988;30(5-6):479-81.
1988: Umberto Tirelli; Emanuela Vaccher; A Ambrosini; A Andriani; I Bianco Silvestroni; G Broccia; T Chisesi; P Dessalvi; marco gobbi; F Fassio
HIV-related malignant lymphoma: a report of 46 cases observed in Italy.
Acta haematologica 1988;80(1):49-51.
1988: A Monteverde; M T Rivano; G C Allegra; A I Monteverde; P Zigrossi; P Baglioni; marco gobbi; Brunangelo Falini; G Bordin; S Pileri
Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections.
Acta haematologica 1988;79(1):20-5.
1988: Andrea Bontadini; marco gobbi; A Dinota; P L Tazzari; M T Rivano; S Pileri
In situ immunocytochemical staining of cell colonies growing in plasma clot.
Histochemistry 1988;89(3):237-40.
1987: M T Rivano; Brunangelo Falini; H Stein; S Canino; C Ciani; J Gerdes; R Ribacchi; marco gobbi; S Pileri
Histiocytic necrotizing lymphadenitis without granulocytic infiltration (Kikuchi's lymphadenitis). Morphological and immunohistochemical study of eight cases.
Histopathology 1987;11(10):1013-27.
1987: Pier Luigi Tazzari; marco gobbi; A Dinota; Andrea Bontadini; G Grassi; C Cerato; Michele Cavo; S Pileri; F Caligaris-Cappio; Sante Tura
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Clinical and experimental immunology 1987;70(1):192-200.
1987: J Gerdes; H Stein; S Pileri; M T Rivano; marco gobbi; E Ralfkiaer; K M Nielsen; G Pallesen; H Bartels; G Palestro
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas.
Lancet 1987;2(8556):448-9.
1987: Pier Luigi Tazzari; marco gobbi; Daniela Zauli; A Tassinari; C Crespi; F Miserocchi; A Dinota; G Bandini; P Ricci; S Tura
Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease.
Transplantation 1987;44(2):234-6.
1987: Francesco Lauria; R Foa'; Nicola Migone; M C Giubellino; Donatella Raspadori; M Buzzi; Giulia Casorati; marco gobbi; Pier Luigi Tazzari; S Tura
Heterogeneity of large granular lymphocyte proliferations: morphological, immunological and molecular analysis in seven patients.
British journal of haematology 1987;66(2):187-91.
1987: S Pileri; J Gerdes; M Rivano; P L Tazzari; M Magnani; marco gobbi; H Stein
Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki-67.
British journal of haematology 1987;65(3):271-6.
1987: A Dinota; P L Tazzari; Andrea Bontadini; G P Grassi; C Cerato; Maria Rosa Motta; G Visani; Michele Cavo; marco gobbi; S Tura
Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myeloma.
Journal of experimental pathology 1987;3(4):363-7.
1987: marco gobbi; L Barbieri; P L Tazzari; A Dinota; Andrea Bontadini; Simonetta Rizzi; A Pession; F Stirpe; S Tura
An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience.
Journal of experimental pathology 1987;3(4):359-62.
1987: Enzo Pasquini; E Tiraferri; Patrizia Fattori; I Fabbri; marco gobbi
Serum beta 2 microglobulin in multiple myeloma and related plasma cell dyscrasias.
Haematologica 1987;72(1):17-21.
1987: P K Hui; A C Feller; S Pileri; marco gobbi; K Lennert
New aggressive variant of suppressor/cytotoxic T-CLL.
American journal of clinical pathology 1987;87(1):55-9.
1986: S Pileri; M T Rivano; E Raise; G Gualandi; marco gobbi; M Martuzzi; F M Gritti; J Gerdes; H Stein
The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex (ARC): a morphological and immunohistochemical study of 90 cases.
Histopathology 1986;10(11):1107-29.
1986: Sante Tura; Patrizio Mazza; Pier Luigi Zinzani; F Verlicchi; Michele Baccarani; F Lauria; M Fiacchini; marco gobbi; Giuseppe Bandini; E Emiliani
Hodgkin's disease (HD): a historical perspective.
European journal of cancer & clinical oncology 1986;22(11):1315-23.
1986: P L Tazzari; Daniela Zauli; D Raspadori; C Crespi; M Magnani; A Tassinari; marco gobbi
Role of target and effector cell structures in natural killer-mediated cytotoxicity.
La Ricerca in clinica e in laboratorio 1986;16(3):443-7.
1986: G Bandini; P Ricci; marco gobbi; P L Tazzari; Maria Rosa Motta; C Guardigli; Simonetta Rizzi; M Baccarani; S Tura
T-cell depletion with the monoclonal antibody Campath 1 to prevent graft-versus-host disease in ten high-risk adult patients.
Haematologica 1986;71(4):307-11.
1986: S Tura; M Cavo; M Baccarani; P Ricci; marco gobbi
Bone marrow transplantation in multiple myeloma.
Scandinavian journal of haematology 1986;36(2):176-9.
1986: M Cavo; M Baccarani; P Galieni; marco gobbi; S Tura
Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients.
Nouvelle revue française d'hématologie 1986;28(3):147-52.
1986: Daniela Zauli; marco gobbi; C Crespi; Pier Luigi Tazzari; F Miserocchi; M Magnani; N Testoni
Vimentin and keratin intermediate filaments expression by K562 leukemic cell line.
Leukemia research 1986;10(1):29-33.
1985: Federico Caligaris-Cappio; G Pizzolo; M Chilosi; L Bergui; G Semenzato; L Tesio; L Morittu; Fabio Malavasi; marco gobbi; R Schwarting
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia.
Blood 1985;66(5):1035-42.
1985: S Pileri; M T Rivano; marco gobbi; D Taruscio; K Lennert
Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immunological study of 30 cases.
Hematological oncology 1985;3(4):243-60.
1985: R Foà; Luca Baldini; G Cattoretti; P Foa; marco gobbi; F Lauria; E Madon; G Masera; R Miniero; P Paolucci
Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study.
British journal of haematology 1985;61(2):251-9.
1985: marco gobbi; Pier Luigi Tazzari; A Tassinari; G Bandini; D Zauli; C Crespi; F Miserocchi; S Tura
Anticytoskeleton autoantibodies and chronic graft versus host disease.
Haematologica 1985;70(5):457-8.
1985: S Pileri; P Mazza; M T Rivano; G Martinelli; G Cavazzini; marco gobbi; D Taruscio; F Lauria; S Tura
Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases.
Histopathology 1985;9(9):905-20.
1985: marco gobbi; P L Tazzari; D Raspadori; M Cavo; S Pileri; S Tura
Meningeal leukemia complicating prolymphocytoid transformation of B-chronic lymphocytic leukemia.
Acta haematologica 1985;74(4):205-7.
1985: M Cavo; P Galieni; marco gobbi; L Baldrati; L Leardini; M Baccarani; S Tura
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis.
Acta haematologica 1985;74(1):27-30.
1985: Federico Caligaris-Cappio; L Bergui; G Pizzolo; M Chilosi; L Tesio; D Campana; G Semenzato; Fabio Malavasi; marco gobbi
The origin of B-chronic lymphocytic leukaemia (B-CLL) and its relationship to hairy cell leukaemia (HCL).
Advances in experimental medicine and biology 1985;186():949-56.
1984: marco gobbi; F Caligaris-Cappio; D Campana; P L Tazzari; L Bergui; M Cavo; S Tura
Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Clinical and experimental immunology 1984;58(3):625-30.
1984: Patrizio Mazza; G Miniaci; F Lauria; marco gobbi; E Emiliani; E Barbieri; S Neri; P Querzani; M Fiacchini; Sante Tura
Prognostic significance of lymphography in stage IIIs Hodgkin's disease (HD).
European journal of cancer & clinical oncology 1984;20(11):1393-9.